ENDRA Life Sciences Inc.
NDRA
$6.46
$1.1922.58%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 159.90K | -1.31M | -3.17M | -1.60M | -1.23M |
| Total Depreciation and Amortization | 39.20K | 39.70K | 39.50K | 39.40K | 32.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.17M | -287.50K | 1.55M | 412.00K | 26.70K |
| Change in Net Operating Assets | 47.70K | 439.60K | -33.80K | -19.40K | 52.80K |
| Cash from Operations | -927.60K | -1.12M | -1.61M | -1.16M | -1.11M |
| Capital Expenditure | -18.70K | -- | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.24M | 450.00K | -3.00M | -- | -- |
| Cash from Investing | 2.22M | 450.00K | -3.00M | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.89M | 263.70K | 4.58M | 149.50K | 857.40K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.89M | 263.70K | 4.58M | 149.50K | 857.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.18M | -405.90K | -31.70K | -1.01M | -256.30K |